Abstract
The authors would like to make the following corrections for the article, “Bruton Tyrosine Kinase (BTK) and its Role in B Cell Malignancy” by J. Buggy and L. Elias in International Reviews of Immunology 31 (02): 119–132.
The discovery and naming of Bruton tyrosine kinase (BTK) derives from the 1952 description of the rare X-linked immunodeficiency (XLA) syndrome by Dr. Ogden Bruton, a pediatrician then in the United States Army [Citation1].
REFERENCE
- Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9:722–728.